|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1991)) |
IUPAC Name ![]() |
| (2R,3S,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 5214 | fludarabine |
Synonyms ![]() |
| 2-F-Ara-A |
| CCRIS 3382 |
| F-Ara-A |
| Fludara® |
Database Links ![]() |
|
| CAS Registry No. | 21679-14-1 (source: Scifinder) |
| ChEMBL Ligand | CHEMBL1568 |
| DrugBank Ligand | DB01073 |
| PubChem CID | 657237 |
| Search Google for chemical match using the InChIKey | HBUBKKRHXORPQB-FJFJXFQQSA-N |
| Search Google for chemicals with the same backbone | HBUBKKRHXORPQB |
| Search PubMed clinical trials | fludarabine |
| Search PubMed titles | fludarabine |
| Search PubMed titles/abstracts | fludarabine |
| Wikipedia | Fludarabine |
| Comments |
| Fludarabine is a chemotherapy drug used to treat blood cancers. |